הלוואות ואשראי לטווח ארוך של החברה: Aquestive Pharma (AQST)

Current price action for Aquestive Therapeutics (AQST) on GURU.Markets is comparable to the 0.00 metric. The business relies on unique PharmFilm soluble films for injection-free CNS and allergy therapies. However, global conflicts and sanctions complicate product export and registration. To mitigate risks, Aquestive Therapeutics (AQST) is expanding its network of third-party manufacturing plants to ensure stable drug production.

This indicator measures the total volume of credit obligations with a maturity of more than one year, allowing for an assessment of long-term financial stability and the cost of servicing borrowed capital. By analyzing the company's long-term debt, investors determine the liquidity shortage risk for Aquestive Therapeutics (AQST), which is critical for a pharmaceutical business during the period of awaiting regulatory approvals and fighting for patent protection.